Journals of Gerontology Series A: Biological Sciences and Medical Sciences Large Type Edition
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Retornaz, F.
Right arrow Articles by Bergman, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Retornaz, F.
Right arrow Articles by Bergman, H.
The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 63:518-522 (2008)
© 2008 The Gerontological Society of America

Usefulness of Frailty Markers in the Assessment of the Health and Functional Status of Older Cancer Patients Referred for Chemotherapy: A Pilot Study

Frederique Retornaz, Johanne Monette, Gerald Batist, Michèle Monette, Nadia Sourial, David Small, Stephen Caplan, Doreen Wan-Chow-Wah, Martine T. E. Puts and Howard Bergman

1 Division of Geriatric Medicine, 2 Solidage Research Group on Integrated Services for Older Persons, Centre for Clinical Epidemiology and Community Studies, and 3 Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Quebec, Canada.

Address correspondence to Johanne Monette, MD, MSc, Division of Geriatric Medicine, Jewish General Hospital, 3755 Côte Sainte-Catherine, Montreal, Quebec, H3T1E2, Canada. E-mail: johanne.monette{at}mcgill.ca

Background. Older cancer patients seen in an oncology clinic seem to be healthier and less disabled than traditional geriatric patients. Choosing the most sensitive tools to assess their health status is a major issue. This cross-sectional study explores the usefulness of frailty markers in detecting vulnerability in older cancer patients.

Methods. The study included cancer patients ≥70 years old referred to an oncology clinic for chemotherapy. Information on comorbidities, disability in instrumental activities of daily living (IADL) and activities of daily living (ADL), and seven frailty markers (nutrition, mobility, strength, energy, physical activity, mood, and cognition) was collected. Patients were classified into four hierarchical groups: 1- No frailty markers, IADL, or ADL disability; 2- Presence of frailty markers without IADL or ADL disability; 3- IADL disability without ADL disability; 4- ADL disability.

Results. Among the 50 patients assessed, 6 (12.0%) were classified into Group 1, 21 (42.0%) into Group 2, 15 (30.0%) into Group 3, and 8 (16.0%) into Group 4. In Group 2, 7 patients (33.3 %) had one frailty marker, and 14 (66.7%) had two or more. The most prevalent of the frailty markers were nutrition, mobility, and physical activity.

Conclusion. The assessment of seven frailty markers allowed the detection of potential vulnerability among 42% of older cancer patients that would not have been detected through an assessment of IADL and ADL disability alone. A longitudinal study is needed to determine whether the use of frailty markers can better characterize the older cancer population and predict adverse outcomes due to cancer treatment.

Key Words: Cancer • Frailty markers • Elderly • Geriatric assessment • Functional status • Disability






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
All GSA journals The Gerontologist
Journals of Gerontology Series B: Psychological Sciences and Social Sciences
Copyright © 2008 by The Gerontological Society of America.